GlassScriptPhysician profile
A'Sha Mable Brown
NPI 1255674719
$1,246.21
in general payments reported to CMS, 2019-2025
20 companies · $92.72 in 2025
The $92.72 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.55 · 2020: $22.64 · 2021: $473 · 2022: $250 · 2023: $155 · 2024: $176 · 2025: $92.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Notal Vision, INC. | $421.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $186.89 | 2019-2025 | Eylea, Eylea Hd |
| Abbvie INC. | $113.04 | 2022-2025 | Ozurdex |
| Bausch & Lomb Americas INC. | $77.44 | 2022-2024 | Xipere |
| Genentech USA, INC. | $72.07 | 2022-2025 | Vabysmo |
| Novartis Pharmaceuticals Corporation | $45.10 | 2019-2021 | |
| Alcon Vision LLC | $42.27 | 2021-2023 | Clareon |
| Astellas Pharma US INC | $30.55 | 2025 | Izervay |
| Dompe US, INC. | $25.21 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $25.15 | 2021 | |
| Sun Pharmaceutical Industries INC. | $24.75 | 2024 | |
| Kala Pharmaceuticals, INC. | $24.75 | 2022 | |
| Eyevance Pharmaceuticals LLC | $23.91 | 2022 | |
| Thea Pharma INC. | $23.06 | 2023 | |
| Aerie Pharmaceuticals, INC. | $22.71 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $19.64 | 2023 | Vabysmo |
| Glaxosmithkline, LLC. | $19.21 | 2024 | Shingrix |
| Oyster Point Pharma, INC. | $18.73 | 2022 | |
| Ani Pharmaceuticals, INC. | $15.48 | 2024 | Purified Cortrophin Gel |
| Apellis Pharmaceuticals, INC. | $15.25 | 2023 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw A'Sha Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.